grant

mRNA Capping Enzyme

Organization HARVARD MEDICAL SCHOOLLocation BOSTON, UNITED STATESPosted 1 Jul 1999Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY2025AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAffectAntibodiesAntiphosphopeptide-Specific AntibodiesAssayBTF2 transcription factorBasal Transcription FactorBasal transcription factor genesBindingBioassayBiochemicalBiological AssayC-terminalCancersCell BodyCell DifferentiationCell Differentiation processCellsChIP assayCharacteristicsChromatinChromatographyCo(beta)-cyano-7''-(2-methyl)adeninylcobamideCollaborationsColorColoring AgentsComplexCoupledCouplingDNA mutationDNA-Dependent RNA Polymerase IIDefectDevelopmentDiseaseDisorderDrugsDyesEC 2.1.1Elongation FactorEngineeringEnzyme GeneEnzymesEventExpression SignatureFoundationsFunctional RNAFundingGTP mRNA guanylyltransferaseGene ExpressionGene Expression ProfileGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGenerationsGenesGenetic ChangeGenetic TechnicsGenetic TechniquesGenetic TranscriptionGenetic defectGenetic mutationGenomicsGoalsHIVHuman Immunodeficiency VirusesImmobilizationIn VitroIndividualKinasesKineticsKnowledgeLAV-HTLV-IIILabelLocationLymphadenopathy-Associated VirusMalignant NeoplasmsMalignant TumorMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMeasuresMediatingMedicalMedicationMessenger RNAMethodsMethyltransferaseMicroscopyModelingModificationMolecularMolecular InteractionMonitorMsecMutationN-terminalNH2-terminalNoncoding RNANontranslated RNANuclear ExtractNucleosomesOrganismPatternPattern RecognitionPeptidesPharmaceutical PreparationsPhenotypePhosphatasesPhospho-Specific AntibodiesPhosphohydrolasesPhosphomonoesterasesPhosphopeptide-Specific AntibodiesPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphorylation State-Specific AntibodiesPhosphospecific AntibodyPhosphotransferase GenePhosphotransferasesPlantsPluripotent Stem CellsProcessProductivityProtein Binding DomainProtein Binding MotifProtein PhosphorylationProtein-Protein Interaction DomainProteinsRNA ExpressionRNA Polymerase BRNA Polymerase IIRNA ProcessingRNA guanylyltransferaseRadialRadiusResolutionSeriesSpecificityStructureSystemTFIIHTIRF MicroscopyTechniquesTestingThinkingTimeTotal Internal Reflection FluorescentTotal Internal Reflection Fluorescent MicroscopyTrans-Activation of Transcription ProteinTrans-Activator of Transcription of HIVTransactivating Regulatory ProteinTranscriptTranscriptionTranscription ElongationTranscription Factor Proto-OncogeneTranscription ProcessTranscription factor genesTransphosphorylasesUntranslated RNAViralVirus-HIVVisualizationWorkYeastsanalysis pipelinearmbasic transcription factor 2cell typecellular differentiationchromatin immunoprecipitationchromatin modificationdevelopmentaldrug/agentexperimentexperimental researchexperimental studyexperimentsfactor Aflexibilityflexiblegene expression patterngene expression signaturegenome mutationimprovedinsightintervention designliving systemm-RNA GuanylyltransferasemRNAmRNA 5'-guanylyltransferasemRNA capping enzymemRNA guanylyltransferasemalignancymethylasemillisecondneoplasm/cancernoncodingorthopedic freezingpluripotent progenitorresolutionssingle moleculestoichiometrytat Proteintherapy designthoughtstranscription factortranscription factor IIHtranscription factor TFIIHtranscriptional profiletranscriptional signaturetransmethylasetreatment design
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary. The long-term goal of this project is to understand how transcription by RNA
polymerase II (RNApII) is coupled to RNA processing, chromatin modifications, and termination. This project

previously produced a model in which the C-terminal domain (CTD) of the RNApII subunit Rpb1 displays

characteristic phosphorylation patterns at different stages of the transcription cycle to promote binding of the

appropriate factors for co-transcriptional RNA processing. The fundamental knowledge generated by this

project provides significant insight into how the CTD phosphorylation cycle affects medically important

processes such as the stimulation of HIV transcription by the viral Tat protein and "pausing" of RNApII at

developmentally regulated genes. This project is necessary to better understand both the enzymes that

mediate the changes in CTD phosphorylation (kinases, phosphatases, etc.) as well as the proteins that

recognize these patterns.

In the next funding period, three specific aims will be pursued, with a focus on measuring dynamics of

events during transcription. The first aim continues our work directly analyzing CTD phosphorylation sites by

mass spectrometry. A modified CTD (msCTD) was engineered to directly assign phosphorylation sites by

mass, and in the previous period we developed a vastly improved peptide chromatography and analysis

pipeline. This will be used to analyze phosphorylation in yeast cells or extracts where various CTD modifying

enzymes are inactivated or depleted, and to determine the specificity of CTD binding proteins or CTD

antibodies. We will also extend msCTD analysis to mammalian and plant cells. The second aim studies three

proteins, each related to CTD phosphorylation and transcription elongation, that possess long “linker” domains

that apparently function as flexible arms. Using multiple approaches, we will probe how Tfb3 connects the

Kin28/Cdk7 kinase module to the body of TFIIH, how the Ctr9 “trestle” functions within the PAF complex to

facilitate transcription through nucleosomes, and how the Abd1 cap methyltransferase functions in elongation.

The third aim continues our single-molecule microscopy analysis of transcription elongation. We can visualize

individual transcription events with up to three fluorescently-labeled transcription factors, providing second to

millisecond time resolution of binding kinetics. We will measure the stoichiometries, order of binding, and

cooperative interactions between multiple CTD binding and elongation complex factors. Altogether, this project

will make a unique contribution to our understanding of gene expression by providing a time-resolved picture of

events that complements inherently static techniques such as structural studies or genomics.

Grant Number: 5R01GM056663-26
NIH Institute/Center: NIH

Principal Investigator: Stephen Buratowski

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →